Sean Kanakaraj, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 28 years
- New York Medical College, 1998
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kanakaraj’s office at (408) 885-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A73175 · Current
Licensed to practise in California · since 2000 · expires 2028-09-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,390
Medicare paid this office $1,390 for 46 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| X-ray of chest, 2 views | 21 | $418 | $20 |
Who their Medicare patients are
46 Original Medicare patients in 2024. Average age 73 · Women 59% · Also on Medicaid 70% · Health risk score 1.16. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 67% · Diabetes 54%.
The office billed $29,318, Medicare allowed $2,315 and paid $1,390; for 61 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 46 | 61 | 73 | 1.16 | $29,318 | $1,390 |
| 2023 | 54 | 68 | 73 | 0.94 | $29,609 | $1,007 |
| 2022 | 29 | 36 | 72 | 1.32 | $15,958 | $659 |
| 2021 | 35 | 50 | 68 | 1.56 | $21,390 | $1,210 |
| 2020 | 24 | 35 | 69 | 1.50 | $13,224 | $489 |
| 2019 | 28 | 41 | 69 | 1.63 | $19,687 | $1,242 |
| 2015 | 26 | 64 | 60 | 4.40 | $19,851 | $5,005 |
| 2014 | 15 | 54 | 69 | 1.51 | $12,506 | $3,323 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| X-ray of chest, 2 views | 27 | $396 | $14 |
2020: 1 service
| X-ray of chest, 2 views | 11 | $71 | $6 |
2019: 1 service
| X-ray of chest, 2 views | 11 | $175 | $16 |
2015: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,302 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,175 | $114 |
2014: 1 service
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $1,041 | $35 |
Medicaid work
$628,189 in 2024
Medicaid paid $628,189 for 11,106 billed services this clinician did in 2024, up to 177 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,192 | $604,790 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 29 | $13,307 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 248 | $8,899 |
| Short return visit (20+ min) | 1,788 | $422 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 264 | $320 |
| Radiologic examination, chest; 2 views | 49 | $212 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 18 | $100 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 18 | $99 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $26 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 27 | $14 |
| Pain severity quantified; pain present (COA) (ONC) | 484 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 280 | $0 |
| 2024 | 11,106 | 22 | 177 | $628,189 |
| 2023 | 4,943 | 14 | 134 | $554,221 |
| 2022 | 5,032 | 12 | 155 | $580,570 |
| 2021 | 5,537 | 16 | 178 | $786,904 |
| 2020 | 3,612 | 8 | 166 | $444,703 |
| 2019 | 2,356 | 8 | 145 | $369,732 |
| 2018 | 2,177 | 12 | 139 | $400,339 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,134 | $553,128 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 110 | $539 |
| Short return visit (20+ min) | 1,646 | $492 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 72 | $63 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 160 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 409 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 174 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 235 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 448 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 238 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 110 | $0 |
| Radiologic examination, chest; 2 views | 14 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,217 | $578,171 |
| Short return visit (20+ min) | 1,967 | $1,779 |
| Short return visit | 309 | $620 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 16 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 156 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 356 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 133 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 170 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 358 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 228 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 103 | $0 |
| Return visit (30+ min) | 19 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,689 | $785,509 |
| Short return visit (20+ min) | 2,309 | $1,022 |
| Short return visit | 532 | $283 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 12 | $51 |
| ELECTROLYTE PANEL | 12 | $13 |
| Creatinine; blood | 12 | $10 |
| Urea nitrogen; quantitative | 12 | $8 |
| Blood glucose (sugar) level | 14 | $8 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 87 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 189 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 77 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 152 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,343 | $439,159 |
| Short return visit (20+ min) | 1,410 | $2,550 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 257 | $2,324 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 27 | $353 |
| Return visit (30+ min) | 81 | $181 |
| Short return visit | 252 | $84 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 31 | $51 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 211 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,099 | $368,000 |
| Short return visit (20+ min) | 1,097 | $1,496 |
| OFFICE/OUTPATIENT VISIT NEW | 31 | $117 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 19 | $66 |
| Blood glucose (sugar) level | 58 | $24 |
| Culture, presumptive, pathogenic organisms, screening only | 25 | $22 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 12 | $8 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 15 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,233 | $399,222 |
| Short return visit (20+ min) | 663 | $599 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 51 | $240 |
| New patient visit (30+ min) | 16 | $97 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 77 | $94 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 28 | $45 |
| HEPATIC FUNCTION PANEL | 15 | $21 |
| Blood glucose (sugar) level | 43 | $12 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 15 | $7 |
| ELECTROLYTE PANEL | 12 | $0 |
| Creatinine; blood | 12 | $0 |
| Urea nitrogen; quantitative | 12 | $0 |
Drugs they prescribed that Part D paid
$10,892
Pharmacies billed $10,892 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
246 generic and fewer than 11 brand-name prescriptions · $10,892 in drug cost · 67 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 18 | $101 | $6 |
| Nitrofurantoin Mono-Macro | 12 | $99 | $8 |
| Naproxen | 31 | $66 | $2 |
| Amlodipine Besylate | 21 | $52 | $2 |
| Cephalexin | 13 | $50 | $4 |
See all 6 drugs
| Amoxicillin-Clavulanate Potass | 18 | $101 | $6 |
| Nitrofurantoin Mono-Macro | 12 | $99 | $8 |
| Naproxen | 31 | $66 | $2 |
| Amlodipine Besylate | 21 | $52 | $2 |
| Cephalexin | 13 | $50 | $4 |
| Atorvastatin | 13 | $47 | $4 |
Year by year
| 2024 | 291 | 163 | None | None | $10,892 |
| 2023 | 230 | 126 | None | None | $18,299 |
| 2022 | 244 | 155 | None | 15% | $9,267 |
| 2021 | 204 | 143 | 0% (0) | None | $4,369 |
| 2020 | 150 | 96 | 0% (0) | 12% | $3,318 |
| 2019 | 175 | 120 | None | 15% | $2,981 |
| 2018 | 180 | 113 | None | 18% | $10,532 |
| 2017 | 26 | 12 | 0% (0) | None | $3,186 |
| 2016 | 29 | 17 | 0% (0) | None | $1,030 |
| 2015 | 92 | 23 | 0% (0) | None | $11,076 |
| 2014 | 15 | None | 0% (0) | 0% | $125 |
| 2013 | 27 | 12 | 0% (0) | None | $691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Doxycycline Monohydrate | 14 | $227 | $16 |
| Atorvastatin | 14 | $216 | $15 |
| Amlodipine Besylate | 12 | $112 | $9 |
| Naproxen | 24 | $90 | $4 |
2022: 3 drugs
| Cephalexin | 12 | $106 | $9 |
| Doxycycline Monohydrate | 11 | $101 | $9 |
| Naproxen | 25 | $96 | $4 |
2021: 5 drugs
| Nitrofurantoin Mono-Macro | 21 | $289 | $14 |
| Triamcinolone Acetonide | 17 | $165 | $10 |
| Doxycycline Monohydrate | 15 | $138 | $9 |
| Amoxicillin-Clavulanate Potass | 15 | $120 | $8 |
| Amoxicillin | 11 | $53 | $5 |
2020: 2 drugs
| Amoxicillin-Clavulanate Potass | 11 | $73 | $7 |
| Amlodipine Besylate | 12 | $72 | $6 |
2019: 2 drugs
| Clindamycin | 21 | $234 | $11 |
| Naproxen | 12 | $48 | $4 |
2018: 1 drug
| Naproxen | 19 | $69 | $4 |
Professional record
- NPI
- 1194853663
- Licence
- CA A73175California A73175: Current · expires 2028-09-30
- Trained
- New York Medical College, 1998 · 28 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 South Bascom Ave, Scvmc-Department of Medicine, San Jose, CA, 95128
- NPI first listed
- 2007-02-28
- NPI last updated
- 2014-02-12
This is when the NPI record was last certified, not a medical board exam.